title: [Effect of FGF-2 on survivin and subcellular location of Smac in human small cell lung cancer cell NCI-H446].
abstract: OBJECTIVE
  To investigate the effect of basic fibroblast growth factor (FGF-2)on survivin and subcellular location of Smac in human small cell lung cancer (SCLC) cell NCI-H446.
  
  
  METHODS
  Western blot was used to detect the expression of survivin protein induced by FGF-2. The release of Smac from mitochondria to cytoplasm affected by FGF-2 was observed by Western blot and immunofluorescence. Apoptosis of NCI-H446 cells was detected with flow cytometry and Hoechst 33258 staining.
  
  
  RESULTS
  The expression of survivin could be up-regulated in response to FGF-2 treatment in NCI-H446 cells, and the level of survivin expression is related to the concentration and time of FGF-2 treatment. FGF-2 could inhibit the release of Smac from the mitochondria to cytoplasm induced by serum starving. FGF-2 could inhibit the apoptosis induced by serum starving.
  
  
  CONCLUSIONS
  FGF-2 up-regulates the expression of survivin protein in NCI-H446 cells, and blocks the release of Smac from mitochondria cytoplasm. Survivin and Smac might play important roles in the apoptosis inhibited by FGF-2.
authors.affiliation: Department of Pathology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
authors.forename: De-sheng
authors.initials: DS
authors.lastname: Xiao
authors.forename: Hui-qiu
authors.initials: HQ
authors.lastname: Cao
authors.forename: Zheng-hao
authors.initials: ZH
authors.lastname: Deng
authors.forename: Xiao-hui
authors.initials: XH
authors.lastname: Qu
authors.forename: Ji-fang
authors.initials: JF
authors.lastname: Wen
authors.forename: Jian-hua
authors.initials: JH
authors.lastname: Zhou
authors.forename: Chun-yan
authors.initials: CY
authors.lastname: Fu
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D051017:Apoptosis Regulatory Proteins; D003593:Cytoplasm / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis*; D008928:Mitochondria / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000378:metabolism*; D055752:Small Cell Lung Carcinoma / Q000378:metabolism* / Q000473:pathology; D000077022:Survivin; D014407:Tumor Cells, Cultured
chemical_list: D051017:Apoptosis Regulatory Proteins; C107489:BIRC5 protein, human; C412403:DIABLO protein, human; D051034:Inhibitor of Apoptosis Proteins; D047908:Intracellular Signaling Peptides and Proteins; D008869:Microtubule-Associated Proteins; D024101:Mitochondrial Proteins; D000077022:Survivin; D016222:Fibroblast Growth Factor 2